Collectively, the above results strongly suggest that CMC‐encapsulated Ad‐IL10 may effectively control the release and production of IL‐10 through intrahepatic injection and subsequently alleviate CCl4‐induced hepatic fibrosis in a mouse model. The gene discussed is IL10; the disease is Hepatic fibrosis.